A Gene-Sequence Swap Using CRISPR to Cure Hemophilia

July 24, 2015

(Medical Xpress) – A Korean team led by Director of the Center for Genome Engineering Jin-Soo Kim, Institute for Basic Science (IBS) and Professor Dong-Wook Kim at Yonsei University has experimented with hemoplia A-derived induced pluripotent stem cells (iPSCs) and hemoplia mice and found a way to correct this inversion and reverse the clotting factor deficiency that causes hemophilia A.